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Arthritis in mice infected with the Lyme disease spirochete, Borrelia burgdorferi, results
from the influx of innate immune cells responding to the pathogen in the joint and is
influenced in part by mouse genetics. Production of inflammatory cytokines by innate
immune cells in vitro is largely mediated by Toll-like receptor (TLR) interaction with Borrelia
lipoproteins, yet surprisingly mice deficient in TLR2 or the TLR signaling molecule MyD88
still develop arthritis comparable to that seen in wild type mice after B. burgdorferi
infection. These findings suggest that other, MyD88-independent inflammatory pathways
can contribute to arthritis expression. Clearance of B. burgdorferi is dependent on the
production of specific antibody and phagocytosis of the organism. As Fc receptors
(FcγR) are important for IgG-mediated clearance of immune complexes and opsonized
particles by phagocytes, we examined the role that FcγR play in host defense and
disease in B. burgdorferi-infected mice. B. burgdorferi-infected mice deficient in the Fc
receptor common gamma chain (FcεRγ−/− mice) harbored ∼10 fold more spirochetes
than similarly infected wild type mice, and this was associated with a transient increase in
arthritis severity. While the elevated pathogen burdens seen in B. burgdorferi-infected
MyD88−/− mice were not affected by concomitant deficiency in FcγR, arthritis was
reduced in FcεRγ−/−MyD88−/− mice in comparison to wild type or single knockout mice.
Gene expression analysis from infected joints demonstrated that absence of both MyD88
and FcγR lowers mRNA levels of proteins involved in inflammation, including Cxcl1 (KC),
Xcr1 (Gpr5), IL-1beta, and C reactive protein. Taken together, our results demonstrate a role
for FcγR-mediated immunity in limiting pathogen burden and arthritis in mice during the
acute phase of B. burgdorferi infection, and further suggest that this pathway contributes
to the arthritis that develops in B. burgdorferi-infected MyD88−/− mice.
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INTRODUCTION
Lyme disease, due to infection with Borrelia burgdorferi sensu lato
spirochetes, is the most common arthropod-borne disease in the
northern hemisphere (Kurtenbach et al., 2006). The disease usu-
ally manifests as the skin lesion erythema migrans at the tick
bite site and can result in myocarditis, arthritis, and neurologi-
cal abnormalities once infection has disseminated (Bockenstedt,
2013). In the United States, arthritis is the second most com-
mon clinical sign of confirmed cases of Lyme disease reported
to the Centers for Disease Control and Prevention (CDC, 2013).
A mouse model of Lyme disease has been developed that mani-
fests primarily as myocarditis and arthritis, although spirochetes
can be found in other, non-diseased tissues such as the skin
(Barthold et al., 1992). Inflammation peaks in the heart and
joints 2–4 weeks after infection introduced by needle inocula-
tion of cultured spirochetes and resolves without treatment in
wild type mice even though spirochetes remain in these tissues
(Barthold et al., 1990). Histopathology of B. burgdorferi-infected
mouse tissues reveals a dominance of innate immune cells at
sites of inflammation, especially macrophages in the heart and
neutrophils in the joints (Barthold et al., 1990, 1992; Ruderman
et al., 1995). This pathology develops in the absence of B and
T cells, but adaptive immunity is required for the spontaneous,
immune-mediated regression of disease (Barthold et al., 1992;
McKisic and Barthold, 2000; Bockenstedt et al., 2001).
B. burgdorferi express an abundant array of lipoproteins
that are potent stimulators of inflammatory responses (Fraser
et al., 1997). Lipoproteins activate macrophages and other innate
immune cells through Toll-like receptor (TLR) pattern recogni-
tion molecules, especially TLRs 2, 5, 7, 8, and 9 (Aliprantis et al.,
1999; Hirschfeld et al., 1999; Wooten et al., 2002; Shin et al., 2008;
Petzke et al., 2009; Cervantes et al., 2011). These TLRs utilize the
common intracellular adaptor molecule myeloid differentiation
primary response gene 88 (MyD88) to initiate intracellular signal-
ing events that culminate in NFκb activation and inflammatory
cytokine production (Creagh and O’Neill, 2006). In vitro stimu-
lation of macrophages by borrelia lipoproteins via TLR2 leads to
the production of chemokines, cytokines, and the upregulation of
costimulatory molecules (Hirschfeld et al., 1999; Shin et al., 2008;
Salazar et al., 2009). While the TLR/MyD88 signaling pathway
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is the main pathway contributing to B. burgdorferi lipoprotein
mediated inflammation in vitro, arthritis and carditis still develop
in vivo in the absence of TLR2 or MyD88 expression (Wooten
et al., 2002; Liu et al., 2004; Behera et al., 2006b). This observa-
tion suggests that otherMyD88-independent pathways contribute
to the development of disease.
Receptors for the Fc region of IgG (FcγR) and immune com-
plexes can also play a role in the development of inflammation
(Nimmerjahn and Ravetch, 2006, 2008). FcγR couple innate
and adaptive immune responses through their ability to activate
effector cells (Nimmerjahn and Ravetch, 2008). Proinflammatory
and anti-inflammatory mechanisms are linked to different FcγR,
which share the common FcR γ-chain (Nimmerjahn and Ravetch,
2006). The high affinity FcγRI, intermediate affinity FcγRIV,
and low affinity FcγRIII and FcεRI, which mediate the binding
and internalization of mouse IgG1, IgG2a, IgG2b, IgG3, and IgE
subclasses, are activating receptors that contain an immunore-
ceptor tyrosine-based activation motif (ITAM) (Nimmerjahn and
Ravetch, 2007). FcγRII is an inhibitory receptor containing an
immunoreceptor tyrosine-based suppressionmotif. FcγR are pre-
dominantly expressed on macrophages, neutrophils, dendritic
cells, and other innate immune cells, and have limited expression
on lymphocytes, including B cells, and NK cells and endothe-
lial cells (Takai, 2005). The outcome from engagement of FcγR
depends on the IgG subclass and the balance between activation
and inhibitory FcγR stimulation.
Mice deficient in the common gamma chain (FcεRγ−/− mice)
lack the ability to mediate IgG dependent phagocytosis and
antibody-dependent cell-mediated cytotoxicity through FcγRI,
FcγRIII, and FcγRIV (Takai et al., 1994). In some infection mod-
els, the ability to control infection is impaired in FcεRγ−/− mice,
as has been reported for intracellular pathogens Plasmodium
and Pneumocystis spp. (Yoneto et al., 2001; Wells et al., 2006).
Yet, with other infections and with some autoimmune mod-
els, the absence of FcγR signaling ameliorates disease (Kima
et al., 2000; Tarzi et al., 2002; Alexander and Scott, 2004; Kaneko
et al., 2006a,b; Giorgini et al., 2008). Antigen-antibody com-
plexes (immune complexes) can trigger inflammation by binding
to and activating FcγR, and these receptors have been shown to
play an integral role in immune complex-mediated tissue injury
(Jancar and Crespo, 2005). When antigens encounter their cog-
nate antibody in the presence of complement, binding of the
complex to the complement C3 protein follows immune com-
plex formation (Wessels et al., 1995; Baudino et al., 2008; Giorgini
et al., 2008). This complex facilitates simultaneous interaction
with both FcγR and complement receptors. Activation of com-
plement can lead to clearance of pathogens as well as the immune
complexes, thereby preventing them from causing further tissue
damage. More recently it has been found that signaling through
both FcγR and TLRs are modulated by ITAM-coupled receptors.
ITAM receptors are activated by immune complexes that crosslink
FcγR, and this high avidity activation synergizes with TLR signals
to activate pro-inflammatory gene expression (Ivashkiv, 2008).
Immune complexes containing B. burgdorferi antigens have
been found early after infection in human plasma sam-
ples (Benach et al., 1984; Schutzer et al., 1999; Lencáková
et al., 2007). Here, we postulated that inflammation in
B. burgdorferi-infected mice could be mediated in part by the
formation of immune complexes, and that this FcγR-mediated
inflammation may contribute to the pathology seen in mice defi-
cient in TLR/MyD88-mediated responses. Our results using mice
deficient in FcγR only or in both FcγR and MyD88 reveal that
FcγR has a dual role in immune defense and arthritis develop-
ment associated with B. burgdorferi infection.
METHODS
MICE
C57Bl/6 (B6);129P2-Fcer1gtm1Rav/J (FcεRγ−/−) mice, 6–8 weeks
of age, were obtained from the Jackson Laboratory (Bar Harbor,
ME, stock number 002847). The B6.129 MyD88−/− mice were
the kind gift of Ruslan Medzhitov, Yale University School of
Medicine (Schnare et al., 2001). FcεRγ−/− mice were bred with
MyD88−/− mice and select progeny were intercrossed to produce
FcεRγ−/− MyD88−/− double knockout mice; the F2 generation
was used in these studies. Wild type and heterozygous littermates
were used as controls. Mice were housed in filter frame cages
and administered food and water ad libitum according to Yale
University animal care and use guidelines. Mice were euthanized
by carbon dioxide asphyxiation. The Yale University Institutional
Animal Care and Use Committee approved all procedures.
INFECTION OF MICE
Frozen aliquots of low-passage B. burgdorferi N40 were grown
to mid-logarithmic phase in BSK-H medium (Sigma-Aldrich, St.
Louis, MO) and enumerated by dark-field microscopy using a
Petroff-Hausser chamber. Each mouse was inoculated intrader-
mally in the central lower back or in each hind limb between
the knee and tibiotarsal joints with 104 spirochetes in 100μl of
BSK-H medium. These inoculation sites were chosen as we have
found that arthritis may be more apparent in a disease-resistant
mouse background such as C67BL/6 or 129 mice if spirochetes
are inoculated closer to the joints examined for histopathology.
Both inoculation sites still result in systemic disseminated infec-
tions. At the time of mouse sacrifice, infection was confirmed by
culturing the blood or a portion of the urinary bladder in BSK-H
medium for 14 days, after which the presence of spirochetes was
determined by dark-field microscopy.
MACROPHAGE STIMULATION
Macrophages were isolated from WT and MyD88−/− mice by
peritoneal lavage according to previously published methods
(Liu et al., 2004). Cells were resuspended in α-minimal essen-
tial medium (MEM) supplemented with 10% heat-inactivated
fetal bovine serum and aliquoted at 2 × 106 cells/ml into a 24-
well plate. Cells were stimulated for 24 h with recombinant lipi-
dated OspC protein (kindly provided by John Dunn, Brookhaven
National Laboratories) or Osp C protein-immune complexes
formed using rabbit polyclonal anti-OspC antisera. We con-
firmed that antibodies present in the rabbit antisera could bind to
mouse FcγR using the J774 mouse macrophage cell line (data not
shown). In order to create the immune complexes, concentrations
of lipidated OspC protein ranging from 0.1 ng to 1μg were incu-
bated with 20μl of rabbit polyclonal anti-OspC antisera (with an
anti-OspC IgG titer of 1:192,000) and 80μl of α-MEMmedia for
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30min prior to incubation with the cells. Negative control sam-
ples contained just the rabbit polyclonal anti-OspC antisera in
media to insure that antisera alone did not stimulate production
of TNFα. Cells were cultured for 24 h in a 37◦C incubator with
5% CO2, after which supernatants were harvested and analyzed
for TNFα production by ELISA as described (Liu et al., 2004).
MEASUREMENT OF B. BURGDORFERI-SPECIFIC ANTIBODY TITERS
B. burgdorferi-specific enzyme-linked immunosorbent assays
were performed using sera from 21-day infected animals as pre-
viously described (Liu et al., 2004). Briefly, 96-well microtiter
plates were coated with B. burgdorferi lysate (3μg in 50μl 100%
ethanol per well). After blocking, serial twofold dilutions of
sera in PBS containing 0.5% bovine serum albumin and 0.5%
Tween 20 were added to the wells and incubated for 1 h at
room temperature. Secondary biotinylated anti-mouse IgM and
IgG (Vector Labs, Burlingame, CA), IgG1, IgG2a, and IgG2b
(Invitrogen, Carlsbad, CA), and IgG3 (BD Biosciences, Franklin
Lakes, NJ) were used at a 1:1000 dilution, and bound Abs were
detected with the ABC Elite peroxidase detection and ABTS
[2,2′-azino-bis(ethylbenzthiazolinesulfonic acid)] substrate kits
(Vector Labs). The mixed B6.129 mouse background permitted
reactivity with IgG2a even though the B6 mouse strain lacks
this subclass and expresses the IgG2c subclass instead (with 70%
homology to IgG2a).
QUANTITATIVE PCR OF B. BURGDORFERI DNA
DNA was isolated from urinary bladder using the DNeasy kit
(QIAGEN Inc., Valencia, CA) according to the manufacturer’s
instructions. This tissue was chosen as representative of pathogen
burden as the entire organ can be processed for DNA extrac-
tion and, as a non-diseased site, the immune response would not
be expected to impact the spirochete quantification. The copy
number of B. burgdorferi in each sample was determined by quan-
titative PCR of the B. burgdorferi recA gene using an iCycler
(Bio-Rad, Hercules, CA), the Brilliant SYBR green kit (Stratagene,
Cedar Creek, TX), and the following primers: 5′ primer 5′-
GTGGATCTATTGTATTAGATGAGGCTCTCG-3′ and 3′ primer
5′-GCCAAAGTTCTGCAACATTAACACCTAAAG-3′. The recA
copy number was normalized to the mouse actin gene amplified
using the following primers and probe: 5′ primer 5′-ATCAGGTA
GTCGGTCAGG-3′, 3′ primer 5′-GGTATCTATCTCGACTC-3′,
and probe 6-carboxyfluorescein-TCCAGCAGATCTGGATCAGC
AAGCA-carboxytetra-methylrhodamine (Applied Biosystems,
Foster City, CA). A 60◦C annealing temperature and 45 or 50
cycles were used for the recA and actin gene reactions, respectively.
Standard curves were generated for both PCRs using known
quantities of DNA. Reactions were performed in duplicate, and
the quantities of PCR products generated were determined from
the standard curves.
HISTOPATHOLOGY
Bilateral hind limb joints (knee and tibiotarsal joints) were fixed
in formalin, embedded in paraffin and sections stained with
hematoxylin and eosin by routine histologic techniques as previ-
ously described (Liu et al., 2004). The knee and tibiotarsal joints
were scored for the presence and severity of periarticular inflam-
mation and arthritis on a scale of 0 (negative) to 3 (severe) in a
blinded fashion as described previously (Liu et al., 2004). Values
for arthritis severity were reported as the mean scores of all the
joints of individual mice in each group ± the standard error of
the mean. Carditis was considered present when inflammatory
cell infiltrates were present in the heart base in tissue sections.
QUANTITATIVE REAL-TIME ARRAY ANALYSIS FOR INFLAMMATORY
CYTOKINES AND RECEPTORS
RNA was extracted from joints of uninfected and 21 day-infected
WT, FcεRγ−/−, MyD88−/−and double knockout mice using
TRIzol® and the PureLink™ micro-to-midi total RNA purifica-
tion system (Invitrogen, Carlsbad, CA). The quality of RNA was
verified in all samples with A260:A230 ratios greater than 1.7,
and A260:A280 ratios between 1.8 and 2.0. RNA was combined
from 4 mice in each group and was converted to complimentary
DNA (cDNA) and real-time PCR was performed on the sam-
ples using the RT2 First Strand Kit and the RT2 qPCR Master
Mix according the manufacturer’s instructions (SABiosciences,
Frederick, MD). Themaster mix containing the cDNAwas loaded
onto the RT2 Profiler PCR Array for Inflammatory Cytokines and
Receptors (SABiosciences, PAMM-011), and the amplification
was performed according to the manufacturer’s protocol using a
Bio-Rad iCycler. The data were analyzed using the Ct method
by the Keck facility (Yale University).
PCR CONFIRMATION OF SELECT MICROARRAY DATA
0.4μl aliquots of cDNA (generated above) were used as templates
for PCR reactions in order to confirm select results obtained with
the microarray. A 60◦C annealing temperature and 35 cycles were
performed for each reaction using Taq polymerase (QIAGEN)
and the following primers: TNFα, 5′ primer 5′atgagcacagaaagca
tgatc 3′ and 3′primer 5′tacaggcttgtcaccgaatt 3′; IL-10, 5′ primer
5′atgcaggactttaagggttacttg3′ and 3′ primer 5′tagacaccttggtcttggag
ctta 3′; IFNγ, 5′ primer 5′gacagaagttctgggcttctcc 3′ and 3′ primer
5′gcagcgactccttttccgctt 3′.
RESULTS
PRESENTATION OF B. BURGDORFERI ANTIGENS AS IMMUNE
COMPLEXES ENHANCES MACROPHAGE PRODUCTION OF TNFα
To examine the response of mouse macrophages to a B. burgdor-
feri antigen alone or in the form of an immune complex,
we stimulated resting peritoneal macrophages from WT or
MyD88−/− mice with recombinant lipidated OspC alone or
as an immune complex with anti-OspC antisera (Figure 1).
As expected, recombinant lipidated OspC elicited TNFα in a
dose-dependent fashion from WT macrophages, whereas there
was little response of MyD88−/− macrophages to this stimu-
lation. In the presence of OspC antibody, however, the dose
of OspC required to stimulate TNFα from WT macrophages
was reduced 100-fold, from 0.01 to 0.0001μg/ml (Figure 1).
MyD88−/− macrophages also produced TNFα when stimulated
with OspC as an immune complex, at levels approaching those
elicited from WT cells. OspC immune serum alone had no
effect (data not shown). These findings indicate that in the
absence of MyD88, macrophages can produce inflammatory
cytokines when B. burgdorferi antigens are presented as immune
complexes.
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FIGURE 1 | TNFα secretion by macrophages stimulated with OspC and
OspC-immune complexes. Peritoneal macrophages from naïve WT and
MyD88−/− mice were stimulated in vitro with recombinant B. burgdorferi
OspC protein or OspC-anti-OspC immune complexes for 24 h. The levels of
secreted TNFα in the supernatants were measured by ELISA.
FCγR DEFICIENCY TRANSIENTLY INCREASES PATHOGEN BURDENS
EARLY AFTER B. BURGDORFERI INFECTION
We next sought to determine the effects of FcγR deficiency on B.
burgdorferi infection and disease in vivo. Although opsonization
of B. burgdorferi is not required for its uptake by macrophages
in vitro (Montgomery et al., 1994), FcγR could contribute to
limiting pathogen burden by enhancing the uptake and lyso-
somal targeting of opsonized B. burgdorferi. We found that
FcεRγ−/− mice have 10-fold higher pathogen burdens as com-
pared to WT mice at day 14 after infection (Figure 2, checkered
bars vs. open bars). MyD88−/− macrophages are known to have
impaired uptake and degradation of B. burgdorferi in vitro (Liu
et al., 2004; Behera et al., 2006a) and MyD88−/− mice exhibit
elevated pathogen burdens after B. burgdorferi infection (Bolz
et al., 2004; Liu et al., 2004). As expected, the pathogen bur-
dens in mice deficient in MyD88 were about 100-fold higher
than those in WT mice (Figure 2, hatched bars), and combined
deficiency in both FcγR and MyD88 did not lead to a further
increase (hatched bars vs. solid black bars). Pathogen burdens
remained elevated in FcεRγ−/− mice through infection day 21,
but by day 45, levels were comparable to those seen in WT
mice. In contrast, MyD88−/− and FcεRγ−/− MyD88−/− still had
significantly elevated pathogen burdens at this late time point
(Figure 2).
DEFICIENCY IN FCγR REDUCES THE SEVERITY OF DISEASE IN
MYD88−/− MICE
In B. burgdorferi-infected mice, absence of TLR signaling
does not diminish the severity of arthritis and in fact, has
even been reported to enhance inflammation (Bolz et al.,
2004). In this situation, IgG opsonization of B. burgdorferi
and/or its membrane blebs could enhance the uptake of spiro-
chetes and their inflammatory components via activating FcγR,
and promote release of inflammatory cytokines, similar to
FIGURE 2 | Quantitative PCR of B. burgdorferi in urinary bladders of
infected mice. The copy number of the B. burgdorferi recA gene was
normalized to the mouse β-actin gene by real-time PCR. Values are
averages of 5–11 individual mice. Results are combined from 2 separate
experiments. At day 14, the burdens in the FcεRγ−/− mice are statistically
different from those in the WT mice (P = 0.0043) and those in the
MyD88−/− and FcεRγ−/− MyD88−/− mice (P = 0.0029 and P = 0.0095,
respectively). At day 21 the FcεRγ−/− mice maintain statistically higher
burdens than the WT mice (P = 0.007) but lower burdens than the
MyD88−/− (P = 0.001) and the FcεRγ−/− MyD88−/− (P ≤ 0.0001). At day
45 there is no difference between the WT and FcεRγ−/− mice but the
MyD88−/− and FcεRγ−/− MyD88−/− burdens remain high. All P-values
were calculated using the Mann-Whitney assay.
what we observed when MyD88−/− macrophages were stim-
ulated with OspC immune complexes in vitro. We therefore
determined the effects of FcγR deficiency alone or in combina-
tion with MyD88 deficiency on B. burgdorferi-induced arthri-
tis. The severity of arthritis was highest in MyD88−/− mice
at day 14, although FcεRγ−/− mice also exhibited a mod-
est increase in joint inflammation relative to WT at this time
point (Figure 3A). At day 21, WT mice had increased arthritis
in comparison to the day 14 timepoint, whereas the arthri-
tis detected in MyD88−/− was less pronounced. FcεRγ−/−
mice had the highest arthritis severity scores relative to WT
or MyD88−/− mice at 21 days of infection. Mice deficient in
both FcγR and MyD88 had minimal arthritis at this time point
(Figure 3B).
ARTHRITIS PREVALENCE IN THE FCεRγ−/− MYD88−/− DOUBLE
KNOCKOUT MICE WAS LOWER THAN THAT OF WT OR SINGLE
KNOCKOUT MICE EARLY AFTER INFECTION
To assess the effects of FcγR deficiency on prevalence of arthri-
tis after B. burgdorferi infection, we determined the num-
ber of joints that had evidence of inflammation in WT and
MyD88−/− mice for comparison with FcεRγ−/− and the dou-
ble knockout FcεRγ−/− MyD88−/− mice (Table 1). At day
14 of infection, the prevalence of arthritis was higher in
MyD88−/− and FcεRγ−/− mice than in WT or FcεRγ−/−
MyD88−/− mice (Table 1). The prevalence remained higher
in each of the single knockout strains as compared to the
WT mice at day 21. At this time point the arthritis in the
double knockout mice was similar in prevalence to what had
been observed in each of the single knockout mouse groups
(Table 1).
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FIGURE 3 | Arthritis severity is diminished in the combined absence of
both FcγR and MyD88. Hind limb joints were analyzed, and each data
point represents one joint. Arthritis was scored on a scale of 0 (negative) to
3 (severe). Four to 14 mice were used in each group and results were
combined from 2 to 4 separate experiments. (A) shows arthritis severity at
day 14, and (B) shows arthritis severity at day 21. Significant differences
were observed in (A): WT vs. MyD88−/− P = 0.007, FcεRγ−/− vs.
MyD88−/− P = 0.004, and MyD88−/− vs. FcεRγ−/− MyD88−/− P = 0.009.
(B) FcεRγ−/− vs. WT P = 0.0026, FcεRγ−/− vs. MyD88−/− P ≤ 0.0001,
FcεRγ−/− vs. FcεRγ−/− MyD88−/−P ≤ 0.0001, MyD88−/− vs. FcεRγ−/−
MyD88−/−P = 0.0003, and WT vs. FcεRγ−/− MyD88−/− P = 0.0013.
P-values were determined using the unpaired Student t test.
MYD88−/− MICE EXHIBIT A DELAY IN THE RESOLUTION OF KNEE
ARTHRITIS THAT IS ABROGATED IN THE ABSENCE OF FCγR
We examined B. burgdorferi-infected mice at a later time point,
day 45, when arthritis is normally subsiding. Mild inflamma-
tion was still present in tibiotarsal joints from each mouse
group at infection day 45 (Table 2). MyD88−/− and WT mice
exhibited comparable degrees of inflammation in these joints
whereas arthritis scores were lower in FcεRγ−/− mice and
FcεRγ−/− MyD88−/− (Table 2). We found that arthritis in
the knees was completely resolved in the WT and FcεRγ−/−
mice and a single joint in one FcεRγ−/− MyD88−/− mouse
had a small amount of inflammation. This was not the case
with MyD88−/− mice, which had the highest prevalence of
arthritis, with 8 of 10 knees showing some degree of inflam-
mation (Table 2). No differences in carditis were observed
Table 1 | Prevalence of arthritis in B. burgdorferi infected mica.
Day of Mouse group
infection
WT FcεRγ − /− MyD88−/− FcεRγ − /−MyD88−/−
14 22/40 60/75b 36/44c 8/16
21 38/75 86/108d 46/58e 51/65f
aArthritis prevalence was reported as the number of joints with inflammation
over the total number of joints examined in each group. The day 14 data are the
prevalence combined from two separate experiments, and at day 21 the data
for the prevalence are combined from four experiments. Statistically significant
differences were found between the following groups.
bFceRγ −/− vs. WT P = 0.009 and vs. FceRγ −/−MyD88−/− P = 0.02.
cMyD88−/− vs. WT P = 0.01 and vs. FceRγ−/−MyD88−/− P = 0.02.
d FceRγ −/− vs. WT P ≤ 0.0001.
eMyD88−/− vs. WT P = 0.001.
f FceRγ −/−MyD88−/− vs. WT P = 0.0008. P-values were determined using the
Fisher’s exact test.
at day 21 and carditis had resolved by day 45 (data not
shown).
FCεRγ−/−MYD88−/− DOUBLE KNOCKOUT MICE HAVE HIGHER
SERUM TITERS OF ANTI-B. BURGDORFERI IGG3 ANTIBODIES THAN
MYD88−/− MICE
We have previously shown that B. burgdorferi-specific IgG in
infected MyD88−/− mice exhibit a shift toward the IgG1 sub-
class, although IgG2a, IgG2b, and IgG3 subclass responses can
still be detected, albeit at lower levels (Liu et al., 2004). At 21
days of infection, FcεRγ−/− mice had anti-B. burgdorferi IgG
subclass responses similar to WT mice (Figure 4). MyD88−/−
mice, as expected, had reduced IgG2a and 2b titers, reduced
IgG3 titers, and increased IgG1 titers compared to WT mice. The
FcεRγ−/−MyD88−/− double knockout mice also had reduced
levels of B. burgdorferi-specific IgG2a and 2b, and elevated IgG1,
similar to the single knockout MyD88−/− mice (Figure 4). The
B. burgdorferi-specific IgG3 levels in the double knockout mice
however, were greater than titers in MyD88−/− single knock-
out mice and similar to those of WT and FcεRγ−/− mice
(Figure 4).
GENE EXPRESSION PROFILES ARE ALTERED IN B. BURGDORFERI
INFECTED FCεRγ−/−MYD88−/− MOUSE JOINTS
To globally assess the cytokines that may be involved with arthri-
tis in our mouse groups, we measured the changes in expression
levels of select cytokine and chemokines in RNA isolated from
knee joints using the RT2 Profiler PCR Array for Inflammatory
Cytokines and Receptors (SA Biosciences). Each mouse group
was analyzed compared to uninfected controls of the same phe-
notype (Table 3). Analysis of knee joint RNA demonstrated that
FcεRγ−/− MyD88−/− mice exhibit a unique expression pattern
that was not seen in either of the single knockouts or in WTmice.
In WT mice, we found that the most abundantly up-regulated
gene in infected joints was the B cell chemokine Cxcl13 (215 fold)
(Table 4). It was also significantly upregulated in the FcεRγ−/−
mice (129 fold) and FcεRγ−/− MyD88−/− (40 fold) infected
joints, but not in the joints of MyD88−/− mice (0.39 fold).
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Table 2 | MyD88-deficient mice exhibit knee arthritis at day 45 of
infection that is reduced in prevalence and severity in the absence of
FcγR.
Mouse strain Joints Arthritis Arthritis
prevalencea severityb
WT Total 7/20 0.45±0.8
Tibiotarsal 7/10 0.9±0.9
Knees 0/10 0
FcεRγ−/− Total 4/20 0.24±0.6
Tibiotarsal 4/10 0.48±0.8
Knees 0/10 0
MyD88−/− Total 16/20c 0.8±0.6d
Tibiotarsal 8/10 1.1±0.8e
Knees 8/10f 0.58±0.4g
FcεRγ−/−MyD88−/− Total 7/20 0.18±0.3
Tibiotarsal 6/10 0.3±0.3
Knees 1/10 0.05±0.16
aArthritis prevalence was reported as the number of joints with inflammation
over the total number of joints examined in each group.
bArthritis was scored on a scale of 0 (negative) to 3 (severe) and reported as the
average score of all the joints examined in each mouse group. Five mice were
used in each group. Statistically significant differences were found between the
following groups.
cMyD88−/− vs. WT P = 0.01, vs. FcεRγ−/− P = 0.004, and vs. FcεRγ−/−
MyD88−/− P = 0.01.
d MyD88−/− vs. WT P = 0.0.04, vs. FcεRγ−/− P = 0.001, and vs. FcεRγ−/−
MyD88−/− P = 0.0008.
eMyD88−/− vs. FcεRγ−/− −MyD88−/− P = 0.02.
f MyD88−/− vs. WT P = 0.007, vs. FcεRγ−/− P = 0.007, and vs. FcεRγ−/−
MyD88−/− P = 0.006.
gFKO vsWT P = 0.04, vs. FcεRγ−/− P = 0.001, and vs. FcεRγ−/− MyD88−/−
P = 0.0008.
c,f Fisher’s exact test.
d,e,gMann-Whitney test.
FcεRγ−/− MyD88−/− joints expressed less Cxcl1, Xcr 1, IL-1β,
and C reactive protein than did the joint tissues from either sin-
gle knockout or WT infected joints (Table 3). In order to confirm
the results of the Superarray, RT-PCR reactions were performed
on a select set of genes using the same RNA as was used on the
array. Results using primers for TNFα, IL-10, and IFNγ show
that the trends for increased or decreased expression or very low
expression were consistent between the array and the PCR results
(Table 4). The Superarray, however, was more sensitive than the
PCR (Table 4).
DISCUSSION
B. burgdorferi lipoproteins have been shown to activate innate
immune cells in vitro through interaction with TLR that signal
the secretion of pro-inflammatory cytokines and chemokines
(Weis and Bockenstedt, 2010). As deficiency in TLR2 or its
intracellular signaling molecule MyD88 is sufficient to elim-
inate B. burgdorferi lipoprotein-induced innate immune cell
FIGURE 4 | Anti-B. burgdorferi IgG subclass titers are different in the
single and double knockout mice. Anti-B. burgdorferi specific titers were
determined by ELISA and are reported as the reciprocal of the endpoint
positive titers. The FcεRγ−/− MyD88−/− anti-B. burgdorferi IgG1 titers are
significantly higher than the MyD88−/− titers (P = 0.0113). The MyD88−/−
IgG 3 titers are significantly lower than the FcεRγ−/− MyD88−/− titers
(P = 0.0025) as well as the WT and FcεRγ−/− titers (P = 0.01 and.0025,
respectively).
activation, the observation that arthritis still occurs in TLR2-
and MyD88-deficient mice suggests involvement of other inflam-
matory pathways. Here, we determined the contribution of
FcγR to host defense and disease associated with B. burgdorferi
infection. Our findings in B. burgdorferi-infected FcεRγ−/−
mice reveal a modest role for FcγR in limiting pathogen burden
early in infection, with spirochete numbers about 10-fold higher
than those found in WT mice. This elevated pathogen burden
was transient and associated with enhanced inflammation in
joints at day 14 after infection, but not thereafter. In contrast,
in later stages of infection when disease is resolving, our results
suggest that FcγR may promote arthritis in MyD88−/− mice, as
elimination of activating FcγR in MyD88−/− mice significantly
attenuates this disease manifestation.
FcγR are thought to bridge innate and adaptive immunity
through the relative engagement of activating and inhibitory
FcγR. The subclasses of IgG produced have different binding
affinities for FcγR, which influences the degree of inflamma-
tory cytokine secretion (Nimmerjahn and Ravetch, 2006). IgG2a
antibodies are the most potent at activating cells and pref-
erentially bind activating FcγRI, whereas IgG1 antibodies are
less activating and bind to low affinity FcγRIII. Our analy-
sis of B. burgdorferi-specific IgG subclasses showed no signif-
icant difference between WT and FcεRγ−/− mouse groups,
so arthritis susceptibility at 14 days of infection cannot be
attributed to a shift toward a more inflammatory IgG subclass.
In murine Lyme borreliosis, IgG is detectable within a week
or so of infection and may serve to opsonize B. burgdorferi
and augment phagocyte clearance of the pathogen. In FcεRγ−/−
mice, phagocytes may rely on TLR/MyD88-dependent pathways
for disposal of B. burgdorferi, with secondary consequences of
enhanced inflammatory cytokine secretion and arthritis in the
early stages of infection. A similar reliance on TLR/MyD88-
dependent responses for pathogen clearance may explain the
effects of complement component C3 deficiency on the course
of murine Lyme borreliosis (Lawrenz et al., 2003). Activation
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Table 3 | Microarray analysis of inflammatory genes expressed in mouse knee joints after B. burgdorferi infection.
Gene WT
Inf/Un
MyD88−/−
Inf/Un
FcεRγ− /−
Inf/Un
MyD88−/−
FcεRγ− /−
Inf/Un
MyD88−/−
ratio/ WT
ratio
FcεRγ− /−
ratio/ WT
ratio
MyD88−/−
FcεRγ− /−ratio/
WT ratio
1-Ccl1 1.97 12.55 1.27 6.06 6.37 0.64 3.08
1-Ccl11 1.15 5.86 0.02 0.64 5.1 0.02 0.56
1-Ccl12 2.66 4.76 0.66 11.79 1.79 0.25 4.43
1-Ccl17 0.13 5.1 0.06 14.83 39.23 0.46 114.08
1-Ccl19 1.18 2.55 2.89 5.54 2.3 2.45 4.69
1-Ccl2 1.8 8.88 3.2 11.88 4.93 1.78 6.6
1-Ccl20 1.95 20.39 6.92 0.99 10.46 3.55 0.51
1-Ccl22 2.41 4.44 0.09 3.66 1.84 0.04 1.52
1-Ccl24 0.21 1.37 0.04 0.45 6.52 0.19 2.14
1-Ccl25 1.04 0.34 0.62 0.78 0.33 0.6 0.75
1-Ccl3 4.08 1.68 2.25 2.1 0.41 0.55 0.51
1-Ccl4 1.74 4.14 0.63 2.17 2.38 0.36 1.25
1-Ccl5 0.34 8.88 0.21 5.35 26.12 0.62 15.74
1-Ccl6 0.25 6.28 0.35 8.22 25.12 1.4 32.88
1-Ccl7 3.66 14.42 2.19 14.83 3.94 0.6 4.05
1-Ccl8 3.94 100.43 0.29 67.18 25.49 0.07 17.05
1-Ccl9 0.34 6.28 0.95 2.62 18.47 2.79 7.71
1-Cx3cl1 0.72 6.73 0.56 1.59 9.35 0.78 2.21
1-Cxcl1 5.46 2.55 2.1 0.54 0.47 0.38 0.1
1-Cxcl10 2.5 26.91 8.51 57.28 10.76 3.4 22.91
1-Cxcl11 N/A 8.88 0.29 5.1 N/A N/A N/A
1-Cxcl12 0.42 0.68 0.18 0.34 1.62 0.43 0.81
1-Cxcl13 215.27 0.39 128.89 40.5 0.002 0.6 0.19
1-Cxcl15 3.73 0.78 1.3 0.51 0.21 0.35 0.14
1-Cxcl9 0.75 26.91 0.98 22.47 35.88 1.31 29.96
2-Ccr1 0.2 3.36 0.11 0.59 16.8 0.55 2.95
2-Ccr2 N/A 2.93 0.07 0.69 N/A N/A N/A
2-Ccr3 0.63 5.1 0.1 0.68 8.1 0.16 1.08
2-Ccr4 0.75 1.46 0.47 1.67 1.95 0.63 2.23
2-Ccr5 1.12 38.05 0.07 1.16 33.97 0.06 1.04
2-Ccr6 1.03 0.84 0.05 0.66 0.82 0.05 0.64
2-Ccr7 0.32 0.9 0.15 0.33 2.81 0.47 1.03
2-Ccr8 0.54 15.45 0.31 0.95 28.61 0.57 1.76
2-Ccr9 0.8 1.04 0.04 0.16 1.3 0.05 0.2
2-Cxcr3 1.32 7.73 0.75 5.74 5.86 0.57 4.35
2-Il8rb 0.37 0.32 0.04 0.17 0.86 0.11 0.46
2-Xcr1 13.74 0.97 0.23 0.15 0.07 0.02 0.01
3-1-Il13 4.56 7.73 0.26 0.51 1.7 0.06 0.11
3-Cd40lg 1.09 1.46 0.04 0.7 1.34 0.04 0.64
3-Ifng 0.8 10.93 0.86 8.82 13.66 1.08 11.03
3-Il10 2.27 530.06 4.38 6.15 233.51 1.93 2.71
3-Il11 0.41 2.22 0.2 0.41 5.41 0.49 1
3-Il15 0.39 3.14 0.19 0.48 8.05 0.49 1.23
3-Il16 0.1 0.78 0.02 0.11 7.8 0.2 1.1
3-Il17b 0.34 1.04 0.23 0.25 3.06 0.68 0.74
3-Il18 0.56 0.84 0.86 1.01 1.5 1.54 1.8
3-Il1a 1.59 12.55 0.96 1.65 7.89 0.6 1.04
3-Il1b 5.74 3.36 1.21 0.86 0.59 0.21 0.15
3-Il1f6 2.45 1.04 2.99 1.34 0.42 1.22 0.55
3-Il1f8 1.41 0.84 1.26 0.46 0.6 0.89 0.33
3-Il20 2.13 0.84 6.41 1.21 0.39 3.01 0.57
(Continued)
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Table 3 | Continued
Gene WT
Inf/Un
MyD88−/−
Inf/Un
FcεRγ− /−
Inf/Un
MyD88−/−
FcεRγ− /−
Inf/Un
MyD88−/−
ratio/ WT
ratio
FcεRγ− /−
ratio/ WT
ratio
MyD88−/−
FcεRγ− /−ratio/
WT ratio
3-Il3 1.27 0.84 4.23 1.05 0.66 3.33 0.83
3-Il4 1.06 14.42 0.33 2.51 13.6 0.31 2.37
3-Itgam 1.44 9.51 0.67 0.58 6.6 0.47 0.4
3-Itgb2 N/A 10.2 3.36 2.81 N/A N/A N/A
3-Lta 0.74 0.26 0.97 0.55 0.35 1.31 0.74
3-Ltb 0.31 0.52 0.03 0.24 1.68 0.1 0.77
3-Mif 0.58 2.55 0.41 0.93 4.4 0.71 1.6
3-Scye1 N/A 0.97 0.64 0.81 N/A N/A N/A
3-Spp1 0.93 0.24 0.66 0.2 0.26 0.71 0.22
3-Tgfb1 0.16 0.9 0.1 0.27 5.63 0.63 1.69
3-Tnf 0.32 16.56 0.25 0.26 51.75 0.78 0.81
4-Il10ra 0.16 5.46 0.22 0.53 34.13 1.38 3.31
4-Il10rb N/A 4.44 0.37 0.57 N/A N/A N/A
4-Il13ra1 0.82 2.38 0.58 1.36 2.9 0.71 1.66
4-Il1r1 N/A 2.38 0.32 0.41 N/A N/A N/A
4-Il1r2 1.85 0.78 1.36 0.99 0.42 0.74 0.54
4-Il2rb 0.18 2.22 0.02 0.45 12.33 0.11 2.5
4-Il2rg 0.29 10.93 0.15 1.03 37.69 0.52 3.55
4-Il5ra 0.99 0.45 0.09 0.44 0.45 0.09 0.44
4-Il6ra 0.56 2.73 0.21 0.74 4.88 0.38 1.32
4-Il6st 0.41 2.07 0.1 0.27 5.05 0.24 0.66
4-Tnfrsf1a 0.03 3.61 0.03 0.07 120.33 1 2.33
4-Tnfrsf1b 0.27 5.46 0.23 0.88 20.22 0.85 3.26
5-Abcf1 0.64 1.27 0.43 0.59 1.98 0.67 0.92
5-Bcl6 0.18 2.55 0.08 0.19 14.17 0.44 1.06
5-C3 0.68 19.03 0.1 2.55 27.99 0.15 3.75
5-Casp1 3.73 1.8 2.1 3.41 0.48 0.56 0.91
5-Crp 1.75 1.11 3.58 0.51 0.63 2.05 0.29
5-Cxcl5 1.12 0.28 0.57 0.3 0.25 0.51 0.27
5-Tollip 0.26 4.14 0.31 0.38 15.92 1.19 1.46
Actb 0.16 2.38 0.26 0.65 14.88 1.63 4.06
Ccr10 0.66 2.22 0.04 0.1 3.36 0.06 0.15
Cxcr5 1.01 0.3 0.14 0.66 0.3 0.14 0.65
Gapdh 0.2 1.68 0.09 0.22 8.4 0.45 1.1
Gusb 0.72 8.28 0.71 1.2 11.5 0.99 1.67
Hprt1 1.41 1.19 2.16 1.74 0.84 1.53 1.23
Hsp90ab1 0.71 0.84 0.65 0.48 1.18 0.92 0.68
Pf4 0.14 0.9 0.23 0.2 6.43 1.64 1.43
PCR-array PAMM—011 (SABiosciences). Values shown in the first four columns are ratios of  ct values from uninfected and infected joints from each strain
(pooled RNA from joints of four mice per group) calculated using the SABiosciences template for analysis. The last three columns show ratios comparing WT ratios
to knockout ratios. The five genes at the end of the table, Gapdh, Gusb, Hprt1, Hsp90ab1, Pf4 are housekeeping genes. Ratios >2 or <0.5 are considered significant
in this assay.
of complement by the classical, lectin, or alternative pathways
results in deposition of C3b on the bacterial surface, enhancing
its killing via C3b-mediated phagocytosis or by membrane attack
complex formation. C3−/− mice infected with B. burgdorferi
harbor ∼3-fold more spirochetes in joints in comparison to
wild type mice and exhibit a trend toward more severe arthri-
tis, which could be due to activation of TLRs (Lawrenz et al.,
2003).
We and others have previously reported that B. burgdor-
feri-infected MyD88−/− mice have markedly elevated pathogen
burdens, but paradoxically, the degree of arthritis is similar to
that observed in WT mice (Bolz et al., 2004; Liu et al., 2004).
MyD88−/− mice have a shift in B. burgdorferi-specific IgG sub-
class to IgG1. Opsonization of spirochetes or their remnants
with this antibody subclass will preferentially activate FcγRIII,
which in many model systems is negatively regulated by FcγRIIb
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Table 4 | Detection of select cytokines by RT-PCR in 21-day infected
mouse joints.
Mouse strain TNFα IL-10* IFNγ
WT Inf/Uninf 0.4 0.0.35 N/A
MyD88−/− Inf/Uninf 136.4 3.5 4.9
FcRγ−/− Inf/Uninf 3.5 1.3 0.13
FcRγ−/− MyD88−/− Inf/Uninf N/A N/A 15.6
RT-PCR was performed using the same RNA that was isolated for the PCR
Super arrays. The amount of PCR product was estimated from the density of
the bands in the agarose gels using ImageJ software. The data reported are the
ratio of density values for Infected sample/Infected tubulin control to Uninfected
sample/Uninfected tubulin controls. N/A, not available. * The levels of IL-10 PCR
product were high for all of the samples thus the magnitude of the differences
calculated by ImageJ are lower than what was observed in the PCR array.
(Nimmerjahn and Ravetch, 2008). This pattern of FcγR engage-
ment in MyD88−/− mice may provide one explanation for the
lack of correlation between the high pathogen burden and disease.
In addition, MyD88−/− mice express higher levels of the anti-
inflammatory cytokine IL-10, which could also lead to reduced
arthritis in the setting of elevated pathogen burdens (Wooten
et al., 2002).
Our studies using FcεRγ−/− MyD88−/− mice have unveiled
a contribution of FcγR and immune complexes to disease. In
vitro, immune complexes can stimulate MyD88−/− macrophages
to produce TNFα, supporting the possibility that FcγR contribute
to arthritis in MyD88−/− mice. In vivo studies with FcεRγ−/−
MyD88−/− double knockout mice reveal lower arthritis sever-
ity scores than either of the single knockout strains or in WT
mice, suggesting that both FcγR andMyD88-dependent pathways
may contribute to the development of arthritis, and each pathway
may take on a more prominent role when the other is inacti-
vated. The dominance of TLR/MyD88-dependent inflammation
over lipidation-independent signaling via FcγR is supported by
an earlier report that B. burgdorferi-induced TNFα production
by bone-marrow derived macrophages from FcεRγ−/− mice was
not significantly reduced compared to wild type macrophages
(Talkington and Nickell, 2001).
To gain further insight into the immune molecules involved in
arthritis development when FcγR orMyD88-dependent pathways
were interrupted, genes expressed in joints from 21 days infected
mice were determined using microarray and compared to unin-
fected control mice of the same genotype. We found differences
in genes expressed among the uninfected control WT and the sin-
gle and double knockout control mice, and each mouse group
exhibited additional differences after infection. More striking dif-
ferences were noted between WT and MyD88−/− mice than
between WT and FcεRγ−/− mice. The FcεRγ−/− MyD88−/−
mice showed decreased expression of several proteins known to
be involved in inflammation as compared to WT and either of
the single knockout mice. The most strongly upregulated gene
in the joints of all the strains except for the MyD88−/− mice
was Cxcl13, a B cell chemoattractant cytokine. Cxcl13 is signif-
icantly upregulated in the cerebrospinal fluid of patients with
acute neuroborreliosis and may serve as a diagnostic marker
for disease (Senel et al., 2010a,b). It has also been found that
Cxcl13mRNA levels are elevated in synovial tissues from rheuma-
toid arthritis patients, but not in osteoarthritic joints (Shi et al.,
2001; Carlsen et al., 2004; Meeuwisse et al., 2011). Cxcl13 may
mediate recruitment of immune cells to infected joints during
infection, but since the MyD88−/− mice (which have reduced
expression of Cxcl13) still develop arthritis, this suggests that
other chemokines may also play significant roles. We did not
isolate and quantify the cell populations in the joints, but his-
tologically the predominant infiltrate in the inflamed joints was
neutrophilic (data not shown). The MyD88−/− mice had large
increases in Ccl8 expression (100 fold) and Cxcl 9 and 10 (both
27 fold). The reduced levels of arthritis incidence and severity in
the FcεRγ−/− MyD88−/− mice correlated with reduced expres-
sion of several chemokines and cytokines compared to the three
other strains. Cxcl1, reduced in FcεRγ−/− MyD88−/− mice, func-
tions to recruit neutrophils (Coelho et al., 2008; Conte et al., 2008;
Grespan et al., 2008; Ritzman et al., 2010), which are a main
component of the cell infiltrates found in arthritic joints of the
infected mice. A decrease in expression of Cxcl1 (also known as
KC)may reduce neutrophil recruitment. WT and single knockout
mice have modest increases in Cxcl1 (ranging from 2–5.5 fold),
which may be sufficient in conjunction with other chemoattrac-
tants to recruit cells to the joint. IL-1β levels were also found to
be lower in the FcεRγ−/− MyD88−/− mice. This may not play a
major role in the reduced disease, however, as we have previously
shown that caspase 1, which cleaves IL-1β into its active form,
is not essential for the control of disease (Liu et al., 2009). The
chemokine receptor Xcr1 was also selectively down regulated in
the FcεRγ−/− MyD88−/− mice. Xcr1 is the receptor for Xcl1 and
Xcl2, which were not part of our microarray, but it is known that
Xcrl also plays a role in rheumatoid arthritis (Wang et al., 2004)
and in the recruitment of cells to arthritic joints (Coelho et al.,
2008; Grespan et al., 2008). Xcr1 was upregulated in the WTmice
(13.7 fold) but not in the FcεRγ−/− or MyD88−/− mice. Taken
together, these results suggest that multiple chemokines and their
receptors contribute to the development of murine Lyme arthri-
tis, and that the molecules involved are similar to those seen
in other forms of antigen-induced and autoimmune-mediated
arthritis.
In summary, our studies reveal a role for FcγR in limiting
pathogen burden and disease in mice early after infection with
the extracellular pathogen Borrelia burgdorferi. We also show that
FcγR may contribute to prolonged arthritis in certain settings,
such as in MyD88−/− mice when phagocytosis is impaired and
pathogen burden is high. Polymorphisms in FcγR have been
found in humans that affect IgG subclass binding and responses
(Kapur et al., 2014), which could influence the outcome from
Lyme disease. Additional studies are needed to determine whether
FcγR and/or polymorphisms in these receptors affect the expres-
sion of human Lyme arthritis.
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